1. Home
  2. EFC vs OCS Comparison

EFC vs OCS Comparison

Compare EFC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$13.45

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$14.11

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
OCS
Founded
2007
2003
Country
United States
Switzerland
Employees
500
60
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EFC
OCS
Price
$13.45
$14.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$14.55
$42.00
AVG Volume (30 Days)
1.5M
614.1K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
11.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$466.06
Revenue Next Year
$43.05
$479.73
P/E Ratio
$9.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.28
$10.52
52 Week High
$14.12
$34.48

Technical Indicators

Market Signals
Indicator
EFC
OCS
Relative Strength Index (RSI) 48.81 43.97
Support Level $13.23 $10.52
Resistance Level $13.80 $21.82
Average True Range (ATR) 0.21 0.68
MACD -0.02 0.91
Stochastic Oscillator 40.68 93.78

Price Performance

Historical Comparison
EFC
OCS

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. It acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: